Dr. Steven Edward Coutre MD

Awards

• Jr. Award for Excellence in Clinical Teaching, Stanford University 1990 Timothy F. Beckett 
• Stanford University 1991 Bernard Cohen Postdoctoral Fellowship 
• Stanford University 2002 Division Teaching Award 

Treatments

• Multiple Myeloma, Blood Disorders, Leukemia And More
• Anemia
• Acute Myeloid Leukemia (aml)
• Lymphoma
• Multiple Myeloma
• Leukemia
• Dermal Aesthetics
• Oral Surgery Procedures
• Extra Corporeal Shockwave Therapy

Fellowships

• Stanford University School of Medicine CA    1992
• Stanford University Hematology    1992
• Stanford University School of Medicine,Stanford, Ca, United States   1992

Publications

• NEW ENGLAND JOURL OF MEDICINETargeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia2013
• JOURL OF CLINICAL ONCOLOGYPhase I Trial of Anti-CD22 Recombint Immunotoxin Moxetumomab Pasudotox2012
• Jourl of the tiol Comprehensive Cancer NetworkOptimizing therapy for acute myeloid leukemia.2008
• BLOODActivity of the tyrosine kise inhibitor PKC4122005
• BLOODThe HP1L1-PDIGFR alpha fusion tyrosine kise in hypereosinophilic syndrome2004
• NEW ENGLAND JOURL OF MEDICINEA tyrosine kise created by fusion of the PDGFRA2003
• Jourl of the tiol Comprehensive Cancer NetworkAcute myeloid leukemia, version 2.2013.2013
• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia, Version 2.2013 Featured Updates to the NCCN Guidelines2013
• HaematologicaSequential azacitidine plus lelidomide combition2013
• JOURL OF CLINICAL ONCOLOGYHigh-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed2013
• AMERICAN JOURL OF HEMATOLOGYAbsolute lymphocyte count at day 28 independently predicts event-free2012
• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia Clinical Practice Guidelines in Oncology2012
• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKAcute Lymphoblastic Leukemia2012
• LEUKEMIASafety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for2012
• LEUKEMIA & LYMPHOMAFil results of a multicenter phase 1 study of lelidomide2012
• HAEMATOLOGICA-THE HEMATOLOGY JOURLTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
• HAEMATOLOGICA-THE HEMATOLOGY JOURLPhase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B2012
• AMERICAN JOURL OF HEMATOLOGYTailored temozolomide therapy according to MGMT methylation status2012
• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia2011
• BRITISH JOURL OF HAEMATOLOGYSouthwest Oncology Group Study S05302010
• Wendtner, C., Hillmen, P., Mahadevan, D., Stilgenbauer, S., Uharek, L.Fil Results of the Phase I Study of Lelidomide In Patients with Relapsed2010
• AMERICAN JOURL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
• JOURL OF CLINICAL ONCOLOGYPhase I and Pharmacologic Study of SNS-0322010
• BRITISH JOURL OF HAEMATOLOGYExpanded safety experience with lelidomide plus dexamethasone in relapsed or refractory multiple2009
• Jourl of the tiol Comprehensive Cancer NetworkAcute myeloid leukemia.2008
• LEUKEMIAIntertiol standardized approach for flow cytometric residual disease monitoring in chronic2007
• AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGYVon Willebrand disease presenting as recurrent hemorrhage after transvagil oocyte retrieval2007
• BRITISH JOURL OF HAEMATOLOGYMinimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?2007
• Jourl of the tiol Comprehensive Cancer NetworkAcute myeloid leukemia clinical practice guidelines in oncology.2006
• LEUKEMIAThe evolving role of alemtuzumab in magement of patients with CLL2005
• BLOODTherapeutic efficacy2004
• CLINICAL LYMPHOMAMagement guidelines for use of alemtuzumab in B-Cell chronic lymphocytic leukemia2004
• SEMIRS IN CANCER BIOLOGYTargeted treatment of hypereosinophilic syndromes2004
• Current hematology reportsMagement of advanced chronic lymphocytic leukemia.2003
• JOURL OF CLINICAL ONCOLOGYCampath-1H treatment of T2002
• TURECONVERSION OF THROMBIN INTO AN ANTICOAGULANT BY PROTEIN ENGINEERING1995
• NEW ENGLAND JOURNAL OF MEDICINETargeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia2013
• LANCET ONCOLOGYOral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients2012
• JOURNAL OF CLINICAL ONCOLOGYPhase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox2012
• BLOODArsenic trioxide improves event-free2010
• Journal of the National Comprehensive Cancer NetworkOptimizing therapy for acute myeloid leukemia.2008
• BLOODDasatinib induces rapid hematologic2007
• BLOODNelarabine induces complete remissions in adults with relapsed or refractory T2007
• BLOODDasatinib induces complete hematologic2007
• BLOODActivity of the tyrosine kinase inhibitor PKC4122005
• BLOODThe HP1L1-PDIGFR alpha fusion tyrosine kinase in hypereosinophilic syndrome2004
• NEW ENGLAND JOURNAL OF MEDICINEA tyrosine kinase created by fusion of the PDGFRA2003
• Journal of the National Comprehensive Cancer NetworkAcute myeloid leukemia, version 2.2013.2013
• JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia, Version 2.2013 Featured Updates to the NCCN Guidelines2013
• HaematologicaSequential azacitidine plus lenalidomide combination2013
• CANCERTreatment of adults with acute lymphoblastic leukemia2013
• JOURNAL OF CLINICAL ONCOLOGYHigh-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed2013
• AMERICAN JOURNAL OF HEMATOLOGYAbsolute lymphocyte count at day 28 independently predicts event-free2012
• JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia Clinical Practice Guidelines in Oncology2012
• JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKAcute Lymphoblastic Leukemia2012
• LEUKEMIASafety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide2012
• LEUKEMIA & LYMPHOMAFinal results of a multicenter phase 1 study of lenalidomide2012
• HAEMATOLOGICA-THE HEMATOLOGY JOURNALTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
• HAEMATOLOGICA-THE HEMATOLOGY JOURNALPhase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B2012
• AMERICAN JOURNAL OF HEMATOLOGYTailored temozolomide therapy according to MGMT methylation status2012
• BLOODResults from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with2011
• JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia2011
• BLOODCD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies2011
• MYCOSESYield of diagnostic procedures for invasive fungal infections2011
• BRITISH JOURNAL OF HAEMATOLOGYSouthwest Oncology Group Study S05302010
• Wendtner, C., Hillmen, P., Mahadevan, D., Stilgenbauer, S., Uharek, L.Final Results of the Phase I Study of Lenalidomide In Patients with Relapsed2010
• AMERICAN JOURNAL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
• CLINICAL LYMPHOMA MYELOMA & LEUKEMIAClassification and Risk Stratification for Acute Promyelocytic Leukemia2010
• JOURNAL OF CLINICAL ONCOLOGYPhase I and Pharmacologic Study of SNS-0322010
• BRITISH JOURNAL OF HAEMATOLOGYExpanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple2009
• LEUKEMIAEfficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid2008
• Journal of the National Comprehensive Cancer NetworkAcute myeloid leukemia.2008
• GYNECOLOGIC ONCOLOGYAcute postoperative thrombotic thrombocytopenic purpura following hysterectomy2007
• LEUKEMIAInternational standardized approach for flow cytometric residual disease monitoring in chronic2007
• AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGYVon Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval2007
• BRITISH JOURNAL OF HAEMATOLOGYMinimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?2007
• UROLOGYRefractory hematuria from amyloidosis successfully treated by splenectomy2006
• Journal of the National Comprehensive Cancer NetworkAcute myeloid leukemia clinical practice guidelines in oncology.2006
• LEUKEMIAThe evolving role of alemtuzumab in management of patients with CLL2005
• BLOODTherapeutic efficacy2004
• CLINICAL LYMPHOMAManagement guidelines for use of alemtuzumab in B-Cell chronic lymphocytic leukemia2004
• SEMINARS IN CANCER BIOLOGYTargeted treatment of hypereosinophilic syndromes2004
• CANCER CELLPKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFR alpha2003
• HematologyT-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).2003
• Current hematology reportsManagement of advanced chronic lymphocytic leukemia.2003
• CLINICAL LYMPHOMACytomegalovirus viremia during Campath-1H therapy for relapsed2002
• Sawyers, C. L., Hochhaus, A., Feldman, E., Goldman, J. M., Miller, C. Imatinib induces hematologic2002
• JOURNAL OF CLINICAL ONCOLOGYCampath-1H treatment of T2002
• Soignet, S. L., Frankel, S. R., Douer, D., Tallman, M. S., Kantarjian,United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia2001
• ONCOLOGY-NEW YORKNCCN Practice Guidelines for acute myelogenous leukemia2000
• NATURECONVERSION OF THROMBIN INTO AN ANTICOAGULANT BY PROTEIN ENGINEERING1995

Experience & Accolades

• Professor of Medicine (Hematology)the Stanford University Medical Center
• MemberLeukemia Committee -- Vice Chair
• Member Disease Management Group Leader-Hematology
• Associate Director 2009 - 2011 Internal Medicine Residency program, Stanford University
• Vice Chair 2011 - 2014 Clinical Affairs, Department of Medicine
• Member2010 - 2014 Stanford Hospital and Clinics
• Member1998 - 2014 Acute Myeloid Leukemia Panel, National Comprehensive Cancer Network
• Member2012 - 2014 Acute Lymphoblastic Leukemia Panel, National Comprehensive Cancer Network
• Member1996 - 2014 Southwest Oncology Group
• Director1996 - 2014 Hematology Clinic, Stanford University

Dr. Steven Edward Coutre MD's Practice location